Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Healthcare & Pharmaceuticals

More than 2 billion doses of COVID-19 vaccines to become available India soon, govt advisor says

1 minute read

A woman receives a dose of COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, at a vaccination centre in Ahmedabad, India, May 1, 2021. REUTERS/Amit Dave

More than 2 billion doses of coronavirus vaccines will likely be available in India between August to December this year, a top government advisor said on Thursday.

Those doses would include 750 million of AstraZeneca's (AZN.L), vaccine, produced in India by the Serum Institute of India, as well as 550 million doses of Covaxin, made by Bharat Biotech, government advisor V K Paul told reporters at a news conference on Thursday.

Several Indian states are reporting an acute shortage of vaccines, even as coronavirus cases surge across the country.

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters